Immunocytochemical study with anti-muscle actin antibody (HHF35) on myocardial ischaemia and reperfusion injury in rats

1993 ◽  
Vol 59 (1) ◽  
pp. 25-34 ◽  
Author(s):  
Fu Chenzhong ◽  
Song Yixuan ◽  
Zhu Jiazhen
Keyword(s):  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Muscle Actin ◽  
Immunocytochemical Study ◽  
Ischaemia And Reperfusion

Protective effects of a plant histaminase in myocardial ischaemia and reperfusion injury in vivo

2003 ◽  
Vol 309 (2) ◽  
pp. 432-439 ◽  
Author(s):  
Emanuela Masini ◽  
Simone Pierpaoli ◽  
Cosimo Marzocca ◽  
Pier Francesco Mannaioni ◽  
Paola Pietrangeli ◽  
...  
Keyword(s):  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Protective Effects ◽  
Ischaemia And Reperfusion

Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO

Shock ◽  
2016 ◽  
Vol 46 (2) ◽  
pp. 202-213 ◽  
Author(s):  
Rosanna Di Paola ◽  
Marika Cordaro ◽  
Rosalia Crupi ◽  
Rosalba Siracusa ◽  
Michela Campolo ◽  
...  
Keyword(s):  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Protective Effects ◽  
Ischaemia And Reperfusion ◽  
Ultramicronized Palmitoylethanolamide

scholarly journals Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo

2002 ◽  
Vol 137 (8) ◽  
pp. 1387-1387
Author(s):  
Emanuela Masini ◽  
Salvatore Cuzzocrea ◽  
Emanuela Mazzon ◽  
Cosimo Marzocca ◽  
Pier Francesco Mannaioni ◽  
...  
Keyword(s):  
Superoxide Dismutase ◽  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Protective Effects ◽  
Ischaemia And Reperfusion

Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury

1995 ◽  
Vol 30 (6) ◽  
pp. 965-974 ◽  
Author(s):  
T. Murohara ◽  
J. Margiotta ◽  
L. M. Phillips ◽  
J. C. Paulson ◽  
S. DeFrees ◽  
...  
Keyword(s):  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Sialyl Lewisx ◽  
Ischaemia And Reperfusion

scholarly journals Changes and Relationship of PAF and TNF in Rats with Myocardial Ischaemia and Reperfusion Injury

1994 ◽  
Vol 3 (3) ◽  
pp. 205-209
Author(s):  
Ya-Ling Han ◽  
Shao-Ha Li ◽  
Qin-Yue Zheng ◽  
Hong-Bin Wang ◽  
Guo-Yan Zhang ◽  
...  
Keyword(s):  
Infarct Size ◽  
Reperfusion Injury ◽  
Myocardial Ischaemia ◽  
Platelet Activating Factor ◽  
Blood Platelet ◽  
Paf Antagonists ◽  
Coronary Ligation ◽  
Ischaemia And Reperfusion ◽  
Relationship Of ◽  
Necrosis Factor

In this study it is reported that: (1) the levels of blood platelet-activating factor and serum tumour necrosis factor significantly increased after coronary ligation and reperfusion, compared with sham-ligated controls, in an anaesthetized rat model; (2) compared with vehicle controls, pretreatment with the PAF antagonist BN 50739 (10 mg/kg, i.v.) produced significant decreases in infarct size (from 29.6 ± 4.0% to 22.4 ± 2.1%,p<0.05after 3 h ligation, and from 28.5 ± 9.5% to 10.5 ± 4.5%,p<0.01after 4 h reperfusion) and the level of serum TNF (from 10.4 ± 7.7 U/ml to 3.9 ± 4.8 U/ml,p<0.05); and (3) a significan positive correlation was found between the level of blood PAF or serum TNF and infarct size. The present results indicate that PAF and TNF may be important mediators involved in myocardial ischaemia and reperfusion injury, and that PAF antagonists may exert a protective effect on ischaemic or reperfused myocardium by inhibiting the interaction of PAF and TNF.

Sign in / Sign up

Export Citation Format

Share Document